XML 73 R52.htm IDEA: XBRL DOCUMENT v3.24.3
Summary of Significant Accounting Policies - Intangible Assets (Details)
3 Months Ended 12 Months Ended
Jun. 29, 2024
USD ($)
Mar. 30, 2024
USD ($)
Dec. 30, 2023
USD ($)
Jul. 01, 2023
USD ($)
Sep. 24, 2022
USD ($)
Jun. 25, 2022
USD ($)
Sep. 28, 2024
USD ($)
Sep. 30, 2023
USD ($)
Sep. 24, 2022
USD ($)
Finite-Lived Intangible Assets [Line Items]                  
Impairment of intangible assets and equipment       $ 174,800,000          
Impairment of intangible assets and equipment       186,900,000     $ 5,600,000 $ 44,300,000 $ 27,700,000
Ultrasound Imaging Assets                  
Finite-Lived Intangible Assets [Line Items]                  
Impairment of intangible assets and equipment       26,400,000          
Ultrasound Imaging Assets, Equipment                  
Finite-Lived Intangible Assets [Line Items]                  
Impairment of intangible assets and equipment       5,800,000          
In-process research and development                  
Finite-Lived Intangible Assets [Line Items]                  
Impairment of intangible assets and equipment       10,500,000          
Minimum                  
Finite-Lived Intangible Assets [Line Items]                  
Intangible assets useful life             5 years    
Maximum                  
Finite-Lived Intangible Assets [Line Items]                  
Intangible assets useful life             30 years    
Developed technology                  
Finite-Lived Intangible Assets [Line Items]                  
Finite-lived intangible assets, net   $ 13,900,000         $ 0    
Trade names                  
Finite-Lived Intangible Assets [Line Items]                  
Finite-lived intangible assets, net   500,000         0    
In-process research and development                  
Finite-Lived Intangible Assets [Line Items]                  
Indefinite-lived intangible assets, fair value       $ 26,500,000          
In-process research and development | Valuation Technique, Discounted Cash Flow                  
Finite-Lived Intangible Assets [Line Items]                  
Measurement input       0.170          
Ultrasound Imaging Assets, Developed Technology                  
Finite-Lived Intangible Assets [Line Items]                  
Impairment of intangible assets and equipment       $ 20,600,000          
Mobidiag                  
Finite-Lived Intangible Assets [Line Items]                  
Accelerated amortization     $ 7,300,000            
Mobidiag | In-process research and development                  
Finite-Lived Intangible Assets [Line Items]                  
Impairment of intangible assets and equipment     4,300,000            
Intangible assets, current     22,400,000       $ 22,400,000    
Impairment of intangible assets and equipment     4,300,000            
Mobidiag | Customer relationship                  
Finite-Lived Intangible Assets [Line Items]                  
Finite-lived intangible assets, net     0            
Mobidiag | Trade names                  
Finite-Lived Intangible Assets [Line Items]                  
Finite-lived intangible assets, net     $ 0            
Mobidiag Oy                  
Finite-Lived Intangible Assets [Line Items]                  
Impairment of intangible assets and equipment       186,900,000          
Mobidiag Oy | Equipment                  
Finite-Lived Intangible Assets [Line Items]                  
Impairment of intangible assets and equipment       12,100,000          
Mobidiag Oy | Trade names                  
Finite-Lived Intangible Assets [Line Items]                  
Impairment of intangible assets and equipment       10,700,000          
Mobidiag Oy | Customer relationship                  
Finite-Lived Intangible Assets [Line Items]                  
Impairment of intangible assets and equipment       10,400,000          
Mobidiag Oy | Developed Technology                  
Finite-Lived Intangible Assets [Line Items]                  
Impairment of intangible assets and equipment       $ 153,700,000 $ 27,700,000        
Focal Therapeutics                  
Finite-Lived Intangible Assets [Line Items]                  
Impairment of intangible assets and equipment   26,800,000              
Focal Therapeutics | Developed technology                  
Finite-Lived Intangible Assets [Line Items]                  
Impairment of intangible assets and equipment $ 13,300,000 25,900,000              
Finite-lived intangible assets, net   13,900,000              
Focal Therapeutics | Trade names                  
Finite-Lived Intangible Assets [Line Items]                  
Impairment of intangible assets and equipment $ 400,000 900,000              
Finite-lived intangible assets, net   $ 500,000              
Focal Therapeutics | Developed Technology                  
Finite-Lived Intangible Assets [Line Items]                  
Impairment of intangible assets and equipment         $ 8,200,000        
Faxitron | Developed Technology                  
Finite-Lived Intangible Assets [Line Items]                  
Impairment of intangible assets and equipment           $ 9,200,000